Avolix Pharmaceuticals

Category: Drugs & Pharmaceuticals

Avolix Pharmaceuticals (Avolix) is a drug discovery and development company founded in 1999. Avolix is developing a portfolio of new and effective treatments for cancer patients worldwide. We have a proprietary drug discovery platform technology that permits us to rapidly identify agents that interact preferentially with cancer cells. These agents contribute to a growing portfolio of cancer treatments that are currently in development. Avolix’ initial portfolio includes treatments for breast cancer, pancreatic cancer, lung cancer, melanoma Glioma and angiogenesis inhibition.